Hereditary transthyretin amyloidosis - vutrisiran - continuing authority application form (PB368)

Use this form to apply to continue PBS-subsidised treatment with vutrisiran for adult patients with hereditary transthyretin amyloidosis.

Page last updated: 1 August 2026.
QC 74416